NATICK and BOSTON, Mass., Jan. 5, 2011 /PRNewswire/ — Boston Scientific Corporation (NYSE:BSX – News) today announced it has acquired Intelect Medical, Inc., a development-stage company located in Boston. Intelect Medical is developing advanced neuromodulation technologies for deep brain stimulation (DBS) therapy. The transaction values Intelect Medical at $78 million with no cash and no [...]

Oct. 28, 2010 Boston Scientific Corp., the Natick-based medical device company, said it has agreed to sell its neurovascular business to Stryker Corp. for up to $1.5 billion as part of Boston Scientific’s strategy to focus on its core business. Plans call for Stryker to pay $1.4 billion at the sale’s closing and Stryker could pay [...]

Latest innovation in plastic biliary stent technology includes features for enhanced deliverability, efficiency and procedural control PR Newswire NATICK, Mass., Oct. 21 NATICK, Mass., Oct. 21 /PRNewswire-FirstCall/ — Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix Biliary [...]

Boston Scientific Corporation is to acquire Athmatx. Inc, from Synnyvale, California for an upfront payment of $193.5 million plus additional payments of up to $250 million. Boston Scientific says it has just signed a definitive merger agreement with Athmatx. Asthmatx designs, makes and sells a less-invasive, catheter-based bronchial thermoplasty procedure for persistentasthma treatment in patients [...]

An unusual airing of a dispute between fierce rivals broke into the open Thursday during a two-and-one-half-hour conference call with financial analysts. Boston Scientifics’ new CEO, Ray Elliott, blasted Little Canada-based St. Jude Medical for hiring several of its former sales personnel who were dismissed last year for “repeatedly breach(ing) our Health Care Professional Code [...]